Literature DB >> 7209549

Tritiated thymidine incorporation does not measure DNA synthesis in ribavirin-treated human cells.

J C Drach, M A Thomas, J W Barnett, S H Smith, C Shipman.   

Abstract

When the incorporation of tritiated thymidine into acid insoluble material was measured, ribavirin appeared to be a potent inhibitor of DNA synthesis in KB cells and human lymphocytes. Inhibition was nearly 100-fold less, however, when DNA synthesis was measured by incorporation of phosphorus-32-labeled phosphate or by DNA fluorescence. The potent inhibition detected by incorporation of tritiated thymidine into DNA actually was the result of a potent effect on the labeling of deoxythymidine triphosphate, not on the synthesis of DNA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7209549     DOI: 10.1126/science.7209549

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  Inhibition of immune functions by antiviral drugs.

Authors:  W Heagy; C Crumpacker; P A Lopez; R W Finberg
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.

Authors:  X B Kong; Q Y Zhu; R M Ruprecht; K A Watanabe; J M Zeidler; J W Gold; B Polsky; D Armstrong; T C Chou
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Use of flow cytometry to study growth of human airway smooth muscle cells.

Authors:  Z D Zhang; G Cox
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

Review 4.  Specific targets for antiviral drugs.

Authors:  E De Clercq
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

5.  Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.

Authors:  E De Clercq; M Cools; J Balzarini; R Snoeck; G Andrei; M Hosoya; S Shigeta; T Ueda; N Minakawa; A Matsuda
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

6.  Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.

Authors:  Alex Kentsis; Ivan Topisirovic; Biljana Culjkovic; Ling Shao; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

Review 7.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

8.  Polyphosphate accumulation in Escherichia coli in response to defects in DNA metabolism.

Authors:  Luciana Amado; Andrei Kuzminov
Journal:  J Bacteriol       Date:  2009-10-16       Impact factor: 3.490

9.  The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

10.  Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.

Authors:  J J Kirsi; P A McKernan; N J Burns; J A North; B K Murray; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.